Trump diagnosed with venous insufficiency, but not serious health problem
In a news conference Thursday, Press Secretary Karoline Leavitt said Trump was diagnosed with chronic venous insufficiency. Leavitt said he underwent a comprehensive examination after noticing swelling in his lower legs in recent weeks.
She said the condition is common in individuals over the age of 70. Trump turned 79 in June.
Leavitt also said Trump's bruises on the back of his hand was caused by frequent handshaking, and the use of aspirin, which he takes for prevention against cardiovascular disease.
She said the exam results showed "no signs of heart failure, renal impairment or systemic illness."
Leavitt also released the physician's memorandum of the diagnosis. She said, "The President remains in excellent health, which I think all of you witness on a daily basis here." She stressed that Trump wanted to release the memorandum "in the effort of transparency."
Former US President Joe Biden, who was 78 when he was sworn in, announced in May that he has been diagnosed with prostate cancer, which had spread to his bones. But Trump questioned the timing of the announcement as it was made after Biden had already left office.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Japan Times
7 hours ago
- Japan Times
Health ministry panel calls for consolidating cancer care provision
A health ministry panel of experts on Friday called for consolidating surgeries and radiotherapies for cancer treatment, with the dwindling number of surgeons in Japan cited as a top reason for the proposed change. The recommendation was part of proposals compiled by the panel, which had studied Japan's cancer treatment provision system toward 2040, when the country is expected to have a significantly older population with fewer people of working age. Shortages of surgeons are expected to accelerate toward 2040, according to the proposals. Radiotherapy devices are expensive and the number of patients who need radiotherapy varies by region. Demand for cancer surgeries is projected to decrease by 5% by 2040, while that for radiotherapy is projected to increase by 24%, according to the panel. Estimating a 3% rise in the number of cancer patients to 1,055,000 by 2040 from the current level and a 39% decrease in the number of gastrointestinal surgeons if the situation stays the same, the panel warned that it may not be possible to maintain currently provided surgical treatments. The panel found consolidation preferable for areas where patients and doctors are limited, as well as cases in which highly advanced techniques are needed. Pediatric cancer and rare cancers were also named as medical fields for which consolidation is desirable. In the meantime, the panel pointed to a need to provide high-quality medical treatment universally in medication therapies, for which demand is expected to increase by 15%, and for elderly cancer patients. Consultative groups involving prefectural governments and key hospitals will discuss cancer treatment provision systems for their own prefectures, the proposals said. The panel called for patient groups' participation in the discussions and gaining the understanding of local residents.
Japan Times
2 days ago
- Japan Times
U.S.-funded contraceptives for poor nations to be burned in France: sources
U.S.-funded contraceptives worth nearly $10 million are being sent to France from Belgium to be incinerated after Washington rejected offers from the United Nations and family planning organizations to buy or ship the supplies to poor nations, according to two sources. A spokesperson for the U.S. State Department confirmed on Wednesday that a decision had been taken to destroy the stock. The supplies have been stuck for months in a warehouse in Geel, a city in the Belgian province of Antwerp, following U.S. President Donald Trump's decision to freeze U.S. foreign aid in January. They comprise contraceptive implants and pills as well as intrauterine devices to help prevent unwanted pregnancies, according to seven sources and a screenshot shared by an eighth source confirming the planned destruction. The U.S. government will spend $167,000 to incinerate the stocks at a facility in France that handles medical waste, the U.S. State Department confirmed. The spokesperson said that a preliminary decision had been made to destroy certain products from terminated U.S. Agency for International Development (USAID) contracts. "Only a limited number of commodities have been approved for disposal," the spokesperson said via email, adding that no condoms or HIV medications would be destroyed. U.S. lawmakers have introduced two bills this month to prevent the destruction of the supplies following Trump's decision to shut down USAID, but aid groups say the bills are unlikely to be passed in time to stop the incineration. The Belgian foreign ministry said Brussels had held talks with U.S. authorities and "explored all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," it said in a statement on Tuesday. "Sexual and reproductive health must not be subject to ideological constraints," it added. The supplies, worth $9.7 million, are due to expire between April 2027 and September 2031, according to an internal document listing the warehouse stocks and verified by three sources. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, said the nongovernmental organization had volunteered to pay for the supplies to be repackaged without USAID branding and shipped to countries in need, but the offer was declined by the U.S. government. "MSI offered to pay for repackaging, shipping and import duties but they were not open to that. ... We were told that the U.S. government would only sell the supplies at the full market value," said Shaw. She did not elaborate on how much the NGO was prepared to pay, but said she felt the rejection was based on the Trump's administration's more restrictive stance on abortion and family planning. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women." She added that many countries in sub-Saharan Africa had relied on USAID for access to contraception and that the aid cuts would lead to a rise in unsafe abortions. The United Nations' sexual and reproductive health agency, UNFPA, also offered to buy the contraceptives outright, three sources said, without disclosing the financial terms of the proposal. However, negotiations broke down, a source with knowledge of the talks said, in part due to a lack of response from the U.S. government. UNFPA declined to comment. One of the sources with knowledge of the issue said that the Trump administration was acting in accordance with the Mexico City Policy, an anti-abortion pact in which Trump reinstated U.S. participation in January. The pact forbids the U.S. government from contributing to or working with organizations providing funding or supplies that offer access to abortions. The source said there was no way for the U.S. government to ensure that UNFPA would not share the contraceptives with groups offering abortions, violating the Mexico City Policy. The State Department also said these were factors in their decision on Wednesday, and added that it had avoided $34.1 million in costs by cancelling other orders placed under the administration of former U.S. President Joe Biden. The source also said the matter was complicated by the fact that the contraceptives in Belgium were embossed with the USAID trademark and Washington did not want any USAID-branded supplies to be rerouted elsewhere. UNFPA did not immediately respond to requests for comment on the concerns raised by the source. One of the two sources who revealed that the stocks of contraceptives were being trucked to France said it would likely take dozens of truckloads and at least two weeks to move the supplies out of the Geel warehouse, with a third source also confirming the scale of the operation. The French government did not immediately respond to requests for comment. Chemonics, the contractor managing the supply chain for USAID's family planning program, declined to comment on the plans to destroy the supplies.
Yomiuri Shimbun
5 days ago
- Yomiuri Shimbun
Investigation of Medical Accidents: Improve The System So That Fairness Is Ensured
Even if there is a system to investigate the causes of medical accidents, that system will not prevent recurrence unless it is used effectively. It is urgent to improve the mechanism. The Health, Labor and Welfare Ministry has begun discussions by a panel of experts on how to improve the safety of medical services. According to the ministry, the panel aims to decide on the course of its discussions by this autumn. The focus of the talks will be issues related to the medical accident investigation system. The investigation system was introduced in October 2015, following revisions to the Medical Service Law. It requires medical institutions to conduct internal investigations and report to third-party organizations when a patient dies unexpectedly at a medical institution. The system is aimed at preventing the recurrence of medical accidents. There is a great significance in using investigations for improving the quality and safety of medical services. They will also help address the concerns of bereaved families, who want to know the truth when a fatal accident occurs. However, this system has repeatedly been criticized for its problems. Since the decision whether to identify an incident as a medical accident is left to the discretion of the head of the medical institution, many facilities are reluctant to conduct investigations. At Kobe Tokushukai Hospital in Kobe, a number of patients died following catheter-based therapies for the heart and other organs, but the hospital did not conduct a thorough investigation. After receiving a whistleblower report, the Kobe municipal government conducted an on-site inspection of the hospital two years ago, and an investigation based on the system was finally carried out. Disputes between medical institutions and bereaved families also persist. It is necessary to establish a mechanism where third-party organizations urge medical institutions to carry out investigations and make reports, rather than leaving the matter solely to the autonomy of medical institutions. It is also important to provide clear criteria for determining which cases are covered under the system. There is also the challenge of ensuring the quality and fairness of investigations. In a case involving the sudden death of a patient who underwent an endoscopy at Juntendo University Hospital in Tokyo, the hospital's internal investigation found no issues. However, a third-party investigation carried out at the request of the bereaved family concluded that the procedure was 'difficult to describe as appropriate.' If medical institutions cannot be trusted regarding the results of their own investigations, the system cannot be said to be functioning properly. It is essential for the government and the medical community to collaborate to establish and promote reliable investigation methods and to make the system more widely used. Another issue that has been raised is the fact that investigations are not conducted unless a patient dies. Medical treatments inherently carry risks, and having no accidents is almost impossible. Therefore, it is the responsibility of medical institutions to deal with medical accidents squarely and make every effort to prevent recurrence. (From The Yomiuri Shimbun, July 20, 2025)
